FnCas9-based CRISPR diagnostic for rapid and accurate detection of major SARS-CoV-2 variants on a paper strip

…, P Kathpalia, A Kanakan, R Maurya, JS Vasudevan… - Elife, 2021 - elifesciences.org
The COVID-19 pandemic originating in the Wuhan province of China in late 2019 has impacted
global health, causing increased mortality among elderly patients and individuals with …

Clinical and immunological benefits of convalescent plasma therapy in severe COVID-19: insights from a single center open label randomised control trial

…, J Sarif, A Lahiri, D Bhowmik, JS Vasudevan… - MedRxiv, 2020 - medrxiv.org
Introduction A single center open label phase II randomised control trial was done to assess
the pathogen and host-intrinsic factors influencing clinical and immunological benefits of …

A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19

…, D Bhowmik, A Lahiri, JS Vasudevan… - Nature …, 2022 - nature.com
A single center open label phase 2 randomised control trial (Clinical Trial Registry of India
No. CTRI/2020/05/025209) was done to assess clinical and immunological benefits of …

Nature and dimensions of systemic hyperinflammation and its attenuation by convalescent plasma in severe COVID-19

…, D Roy, R Chakraborty, JS Vasudevan… - The Journal of …, 2021 - academic.oup.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing
coronavirus disease 2019 (COVID-19), has led to significant morbidity and mortality. While most …

Increased abundance of Achromobacter xylosoxidans and Bacillus cereus in upper airway transcriptionally active microbiome of COVID-19 mortality patients indicates …

…, A Kanakan, K Khare, JS Vasudevan… - Microbiology …, 2022 - Am Soc Microbiol
The modulators of severe COVID-19 have emerged as the most intriguing features of SARS-CoV-2
pathogenesis. This is especially true as we are encountering variants of concern (…

[HTML][HTML] Clinical, serological, whole genome sequence analyses to confirm SARS-CoV-2 reinfection in patients from Mumbai, India

…, C Sharma, A Kanakan, J Srinivasa Vasudevan… - Frontiers in …, 2021 - frontiersin.org
Background: SARS-CoV-2 infection may not provide long lasting post-infection immunity.
While hundreds of reinfections have reported only a few have been confirmed. Whole genome …

Noncoding RNAs: modulators and modulatable players during infection-induced stress response

…, J Srinivasa Vasudevan… - Briefings in functional …, 2021 - academic.oup.com
The human genome has an almost equal distribution of unique and transposable genetic
elements. Although at the transcriptome level, a relatively higher contribution from …

Whole genome sequencing confirmed SARS-CoV-2 reinfections among healthcare workers in India with increased severity in the second episode

…, C Sharma, A Kanakan, J Srinivasa Vasudevan… - 2020 - papers.ssrn.com
Background: Frontline healthcare workers (HCWs) are exceedingly exposed to SARS-CoV-2
and reinfections are a possibility. A RT-PCR positive test does not confirm reinfection. …

Threading the pieces together: integrative perspective on SARS-CoV-2

A Kanakan, N Mishra, J Srinivasa Vasudevan, S Sahni… - Pathogens, 2020 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has
challenged the research community globally to innovate, interact, and integrate findings across …

Clinico-genomic analysis reveals mutations associated with COVID-19 disease severity: possible modulation by RNA structure

…, P Devi, R Chauhan, A Kanakan, JS Vasudevan… - Pathogens, 2021 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) manifests a broad spectrum
of clinical presentations, varying in severity from asymptomatic to mortality. As the viral …